I have a bachelor degree and I have evaluated my degree by PEBC & I have already received my ECA report that stated:
"Bachelor of Science in Pharmacy degree" - 5 years length
i.e. I will get the score of the professional degree not a normal bachelor degree.
Here are my 2 questions:
1. I am a senior medical science liaison in a multinational pharmaceutical company since 2015. (previously worked as Medical sales rep. for 2 years)
What is the most appropriate NOC, Is it 3131 or 4165? (Job duties are mentioned by the end of the thread)
2. If I will have filled my EE profile with NOC 4165, will my "Professional degree needed to practice in a licensed profession" degree points be lost and considered as Bachelor degree not a professional degree?
Here is My job description:
"Bachelor of Science in Pharmacy degree" - 5 years length
i.e. I will get the score of the professional degree not a normal bachelor degree.
Here are my 2 questions:
1. I am a senior medical science liaison in a multinational pharmaceutical company since 2015. (previously worked as Medical sales rep. for 2 years)
What is the most appropriate NOC, Is it 3131 or 4165? (Job duties are mentioned by the end of the thread)
2. If I will have filled my EE profile with NOC 4165, will my "Professional degree needed to practice in a licensed profession" degree points be lost and considered as Bachelor degree not a professional degree?
Here is My job description:
-Provide thorough up-to-date medical and scientific expertise.
The Medical Science Liaison (MSL) is a healthcare consulting professional representing the pharmaceutical company as an extension into the medical healthcare community
Medical Science Liaison will be accountable for bridging the education, information and awareness gap between the industry and the medical community by functioning as the intermediary between the pharmaceutical company and the physician, serving roles in both the transmission of beneficial compound information and the gathering of in-field medical intelligence.
KEY RESPONSIBILITIES:
Interaction with physicians and Key Opinion Leaders (KOL):
Disease management:
Disease awareness:
- Provide KOls with the necessary information and educational materials to discuss and safely prescribe medication to their patients and to ensure standardization of messaging transmitted within the medical community. The educational material may include, but is not limited to, clinical trial results, safety and efficacy data, educational updates specific to a therapeutic area, continuing medical education, and speaking opportunities.
- The educational perspective allows for the development of important networks with KOLs and decision makers to ensure a healthy product lifecycle.
- Conduct events such as advisory board meetings, speaker training, workshops and conferences.
- Share with the KOLs products’ information including scientific articles and recent guidelines.
- On reactive basis, responding to KOL queries about the off label use of the pharmaceutical company products.
- Obtain feedback that provides insight for physician initiated trials, clinical trial possibilities, educational platform development, safety, and compliance.
Development:
- Increase disease state awareness among KOLs in discussing the latest therapies and provide assistance in building knowledge specific to targeted disease pathways.
- Identify new and innovative medical findings in different regions which may result in the development of publications and providing unique data and insight to these respective regions.
- Through regular accessibility to diverse medical journals, encourages KOLs being updated to the recent publications and international guidelines and Update KOLs on press releases (New studies and partnerships).
- Support the pharmaceutical company' speakers at scientific meetings through speaker briefings and preparing slides and presentations .
- Answer KOL queries through Q&As and Bibliographic searches
Ensuring Patients’ safety & compliance:
- Effectively communicate and distribute relevant educational materials, which enhance awareness within the healthcare community and prioritize the benefit for patients and aid in the enhancement of the practice of medicine. Emphasis is placed on existing data which supports the importance of establishing and maintaining national patient safety goals
- Ensure compliance to local & global pharmacovigilance reporting procedures & timelines